Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S307000, C514S336000, C514S352000, C514S365000, C514S367000, C514S369000, C514S370000, C514S371000, C514S378000, C514S379000, C514S393000, C514S397000, C514S406000, C514S415000, C514S419000, C514S424000, C514S427000, C514S438000, C514S443000, C514S444000, C514S445000, C514S447000, C514S448000, C514S469000, C514S471000, C514S539000, C514S562000, C514S563000, C546S147000, C546S280400, C546S309000, C548S180000, C548S188000, C548S194000, C548S195000, C548S200000, C548S204000, C548S241000, C548S247000, C548S
Reexamination Certificate
active
07105564
ABSTRACT:
The present invention provides novel compounds having a dual antagonistic activity against thromboxane A2 receptor and prostaglandin D2receptor and pharmaceutical compositions comprising them.A compound of the formula (I):wherein R1is —CH2—CH═CH—CH2—CH2—CH2—COOR2or —CH═CH—CH2—CH2—CH2—COOR2; R2is hydrogen or alkyl; m is 0 or 1; p is 0 or 1; X1and X3each is independently optionally substituted aryl or optionally substituted heteroaryl; X2is a bond, —CH2—, —S—, —SO2—, —CH2—O—, —O—CH2—, —CH2—S—, —S—CH2—, or the like; X4is —CH2—, —CH2—CH2—, —C(═O)—, or the like, have a dual antagonistic activity against both a thromboxane A2receptor and a prostaglandin D2receptor.
REFERENCES:
patent: 6172113 (2001-01-01), Ohtani et al.
patent: 6384075 (2002-05-01), Ohtani et al.
patent: WO 97/00853 (1997-01-01), None
patent: WO99/15502 (1999-04-01), None
Tsuri et al., Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane Derivative: Orally Active, Potent, and Selective Prostaglandin D.sub.2 Receptor Antagonists, Journal of Medicinal Chemistry, vol. 40, No. 22, pp. 3504-3507, 1997.
Arimura Akinori
Hiramatsu Yoshiharu
Honma Tsunetoshi
Coleman Brenda
Foley & Lardner LLP
Shionogi & Co. Ltd.
LandOfFree
Pharmaceutical composition comprising a dual antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising a dual antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a dual antagonist... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569195